Paolo Lombardi
Naxospharma srl Cesate, Italy
Biography
Paolo Lombardi graduated from Milan University and completed his PhD from Southampton University. He has over 35 yr experience in the pharmaceutical industrial setting. He has backgrounds in organic synthetic chemistry, process research chemistry and therapeutic chemistry. As Vice-president for Chemistry in Menarini Ricerche, he fostered the discovery of Sabarubicin, a 3rd generation antitumor anthracycline presently in advanced clinical studies. He acted as a consultant for the pharma company IBI G. Lorenzini and the French start up biotech Chrysalon. He founded his own small biotech company, Naxospharma, which has been the recipient of research grants from several national and European funding agencies, and co-founded Aesis Therapeutics, a start-up shell company aimed at developing Naxospharma\'s findings. He is the inventor of over 70 patents in Medicinal and Process Chemistry, author and co-author of over 150 research papers, reviews, abstracts, invited lectures and seminars. He has teaching appointments at Universities, Master courses & Specialist Schools. He is the member of several scientific societies.
Abstract
Abstract : Recent advances in antitumour berberine